Warning: count(): Parameter must be an array or an object that implements Countable in /home/customer/www/drugtrialsformoney.com/public_html/wp-content/plugins/redux-framework/redux-core/inc/classes/class-redux-output.php on line 373
Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers - Drug Trials For Money - Paid Clinical Trials

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers

Study of Nivolumab and Ipilimumab in Children and Young Adults With INI1-Negative Cancers
Conditions:   Malignant Rhabdoid Tumor;   Rhabdoid Tumor of the Kidney;   Epithelioid Sarcoma;   Chordoma (Poorly Differentiated or De-differentiated);   Atypical Teratoid/Rhabdoid Tumor;   Other INI1 Negative Malignant Tumors (With PI Approval)
Interventions:   Drug: Nivolumab;   Drug: Ipilimumab
Sponsor:   Dana-Farber Cancer Institute
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

June 10, 2020 / by / in
Comments